Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial from Genentech evaluates the safety, pharmacokinetics, and activity of RO7656594 in patients with advanced or metastatic prostate cancer and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• RO7656594

Snippet

Sponsor: Genentech, Inc. | Conditions: Advanced Prostate Cancer, Metastatic Prostate Cancer | Phase 1 | Status: RECRUITING